14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of UBX
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Unity Biotechnology Inc. stock price ended at $1.47 on Wednesday, after losing 1.34%.
(Updated on Apr 24, 2024)

Sell candidate since Apr 12, 2024 Loss -3.29% PDF

The Unity Biotechnology Inc. stock price fell by -1.34% on the last day (Wednesday, 24th Apr 2024) from $1.49 to $1.47. During the last trading day the stock fluctuated 2.74% from a day low at $1.46 to a day high of $1.50. The price has fallen in 6 of the last 10 days and is down by -2.65% for this period. Volume has increased on the last day by 48 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 82 thousand shares were bought and sold for approximately $119.99 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -16.66% during the next 3 months and, with a 90% probability hold a price between $1.12 and $1.44 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

UBX Signals & Forecast

There are few to no technical positive signals at the moment. The Unity Biotechnology Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.50 and $1.55. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Monday, April 01, 2024, and so far it has fallen -11.45%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Unity Biotechnology Inc. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".

Support, Risk & Stop-loss for Unity Biotechnology Inc. stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.0400 between high and low, or 2.74%. For the last week, the stock has had daily average volatility of 2.44%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (UBX) For The Upcoming Trading Day Of Thursday 25th

For the upcoming trading day on Thursday, 25th we expect Unity Biotechnology Inc. to open at $1.48, and during the day (based on 14 day Average True Range), to move between $1.41 and $1.53, which gives a possible trading interval of +/-$0.0571 (+/-3.89%) up or down from last closing price. If Unity Biotechnology Inc. takes out the full calculated possible swing range there will be an estimated 7.77% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $1.57, some $0.100 (6.80%) from the current price of $1.47, our system finds the risk reward not very attractive.

Is Unity Biotechnology Inc. stock A Buy?

Unity Biotechnology Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -3.550 Sell Candidate Unchanged

Predicted Opening Price for Unity Biotechnology Inc. of Thursday, April 25, 2024

Fair opening price April 25, 2024 Current price
$1.48 ( 0.454%) $1.47

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for UBX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 1.52 3.17 %
R2 1.50 2.14 %
R1 1.49 1.49 %
Current price: 1.47
Support S1 1.46 -0.586 %
S2 1.45 -1.23 %
S3 1.44 -2.27 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 1.80 22.45 %
R2 1.70 15.65 %
R1 1.57 6.80 %
Current price 1.47
Support S1 0 .
S2 0 .
S3 0 .

FAQ

What is the symbol for Unity Biotechnology Inc. Stock and on which exchange is it traded?
The symbol for Unity Biotechnology Inc. is UBX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Unity Biotechnology Inc. Stock?
Unity Biotechnology Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Unity Biotechnology Inc. Stock?
Unity Biotechnology Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Unity Biotechnology Inc. Stock.

What's the current price of Unity Biotechnology Inc. Stock?
As of the end of day on the Apr 24, 2024, the price of an Unity Biotechnology Inc. (UBX) share was $1.47.

What is the 52-week high and low for Unity Biotechnology Inc. Stock?
The 52-week high for Unity Biotechnology Inc. Stock is $3.79 and the 52-week low is $1.46.

What is the market capitalization of Unity Biotechnology Inc. Stock?
As of the Apr 24, 2024, the market capitalization of Unity Biotechnology Inc. is 24.676M.

When is the next earnings date for Unity Biotechnology Inc.?
The upcoming earnings date for Unity Biotechnology Inc. is May 14, 2024.
Click to get the best stock tips daily for free!

About Unity Biotechnology Inc.

Unity Biotechnology. Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company's lead drug candidate includes UBX1325, which is Phase II clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular degeneration, and diabetic retinopathy. It also develops UBX1967 for the treatment of ophthalmologic dis... UBX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT